Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

MedImmune Files BLA For Pediatric RSV Candidate

04 Feb 2008

PDUFA date for Numax (motavizumab) would be Nov. 30 under standard review.

Related Content

MedImmune Inks Third Reverse Genetics Licensing Deal For Influenza Vaccines

24 Aug 2007

MedImmune Delays Numax BLA Pending Additional RSV Trial Data

07 Feb 2007

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.